Skip to main content
placeholder image

A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.

Journal Article


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2015

Citation


  • Barbour, A., O'Rourke, N., Samra, J. S., Haghighi, K. S., Kench, J., Mitchell, J., . . . Goldstein, D. (2015). A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.. Journal of Clinical Oncology, 33(3_suppl), 387. doi:10.1200/jco.2015.33.3_suppl.387

Web Of Science Accession Number


Start Page


  • 387

End Page


  • 387

Volume


  • 33

Issue


  • 3_suppl

Place Of Publication


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2015

Citation


  • Barbour, A., O'Rourke, N., Samra, J. S., Haghighi, K. S., Kench, J., Mitchell, J., . . . Goldstein, D. (2015). A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.. Journal of Clinical Oncology, 33(3_suppl), 387. doi:10.1200/jco.2015.33.3_suppl.387

Web Of Science Accession Number


Start Page


  • 387

End Page


  • 387

Volume


  • 33

Issue


  • 3_suppl

Place Of Publication